Effects of angiotensin II and losartan in the forearm of patients with essential hypertension

被引:0
|
作者
Baan, J
Chang, PC
Vermeij, P
Pfaffendorf, M
van Zwieten, PA
机构
[1] Leiden Univ, Med Ctr, Dept Nephrol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Pharm, NL-2300 RC Leiden, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Pharmacotherapy, NL-1105 AZ Amsterdam, Netherlands
关键词
angiotensin II; losartan; hypertension; forearm blood flow;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective Angiotensin II type 1 receptor-mediated constrictor effects may be modulated by hypertension-related vascular changes, changes in receptor function and in neurohumoral activity. Design The forearm blood flow (FBF) effects of angiotensin II, methoxamine, and losartan were investigated in essential hypertensive patients. Minimal forearm vascular resistance was measured to determine structural vascular changes. Methods Seven hypertensive patients were selected, and seven matched normotensives. Angiotensin II (0.01-10 ng/kg per min) was infused during predilatation by sodium nitroprusside (6.1 +/- 0.6 ng/kg per min) before and during losartan infusion (0.3-3 mu g/kg per min). Methoxamine (0.2-2 mu g/kg per min) was co-infused with the nitric oxide synthase inhibitor N-G-monomethyl-L-arginine. FBF, measured by venous occlusion plethysmography, was expressed as the change in FBF ratio (FBFinfused arm/FBFnon-infused arm). Results Baseline FBF (infused arm) was increased by sodium nitroprusside from 2.56 +/- 0.80 to 5.46 +/- 0.92 (P< 0.05) and from 2.66 +/- 0.25 to 5.42 +/- 0.40 ml/100 ml per min (P< 0.05) in the hypertensive and normotensive group, respectively. Baseline forearm vascular resistance (FVR) was higher in the hypertensive than in the normotensive group [51 +/- 8 versus 33 +/- 3 mmHg/(ml/100 ml per min); P< 0.05]. Angiotensin II caused a maximal change in FBF ratio (E-max) by -70 +/- 3 and -72 +/- 6% in the hypertensive and normotensive group, respectively (NS). Tachyphylaxis did not occur. Infusions of losartan at 0.3, 1 and 3 mu g/kg per min reduced the E-max values from -70 +/- 3 to -50 +/- 5, -45 +/- 5 and -15 +/- 2%, respectively, in the hypertensive group, and from -72 +/- 6 to -62 +/- 4, -45 +/- 2 and -32 +/- 2%, respectively, in the normotensive group (NS). Infusion of methoxamine significantly reduced the FBF ratio by -58 +/- 6 and -69 +/- 5% in the hypertensive and normotensive groups, respectively (NS). Minimal FVR, after forearm ischemia, was the same in hypertensives and normotensives, namely 3.2 +/- 0.7 and 3.2 +/- 0.4 mmHg/(ml per 100 ml per min), respectively (NS). Conclusions Angiotensin II type 1- and alpha(1)-mediated vascular effects were unchanged by essential hypertension. Baseline FVR was greater in the hypertensives than in the normotensives, while minimal FVR was the same. These results indicate that the forearm vascular bed of the patient group studied does not show important structural and renin-angiotensin system-related functional changes as a result of hypertension. J Hypertens 16:1299-1305 (C) 1998 Lippincott Williams & Wilkins.
引用
收藏
页码:1299 / 1305
页数:7
相关论文
共 50 条
  • [1] Effects of angiotensin II and losartan on forearm blood flow in patients with essential hypertension
    Baan, J
    Chang, PC
    Vermeij, P
    Pfaffendorf, M
    van Zwieten, PA
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 : U166 - U166
  • [2] Forearm blood flow responses to angiotensin II and losartan in patients with essential hypertension
    Baan, J
    Chang, PC
    Vermeij, P
    Pfaffendorf, M
    van Zwieten, PA
    JOURNAL OF HYPERTENSION, 1998, 16 : S129 - S129
  • [3] HEMODYNAMIC AND HUMORAL EFFECTS OF THE ANGIOTENSIN-II ANTAGONIST LOSARTAN IN ESSENTIAL-HYPERTENSION
    GROSSMAN, E
    PELEG, E
    CARROLL, J
    SHAMISS, A
    ROSENTHAL, T
    AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (12) : 1041 - 1044
  • [4] Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension
    Tikkanen, I
    Omvik, P
    Jensen, HA
    JOURNAL OF HYPERTENSION, 1995, 13 (11) : 1343 - 1351
  • [5] A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension
    Hedner, T
    Oparil, S
    Rasmussen, K
    Rapelli, A
    Gatlin, M
    Kobi, P
    Sullivan, J
    Oddou-Stock, P
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 414 - 417
  • [6] Effects of selective angiotensin II type 1 receptor blockade with losartan on arterial compliance in patients with mild essential hypertension
    Klemsdal, TO
    Moan, A
    Kjeldsen, SE
    BLOOD PRESSURE, 1999, 8 (04) : 214 - 219
  • [7] Effects of angiotensin II receptor blockade with losartan on plasma prostanoid production and platelet function in essential hypertension
    Doumas, M
    Douma, S
    Petidis, K
    Vogiatzis, K
    Basagiannis, H
    Zamboulis, C
    JOURNAL OF HYPERTENSION, 2003, 21 : S51 - S52
  • [8] Assessment of effect of angiotensin II receptor antagonist losartan on aortic distensibility in patients with essential hypertension by echocardiography
    Yang Haoyi
    Deng Youbin
    Li Chunlei
    Bi Xiaojun
    Pan Min
    Chang Qing
    Current Medical Science, 2002, 22 (2) : 164 - 167
  • [9] Assessment of effect of angiotensin II receptor antagonist losartan on aortic distensibility in patients with essential hypertension by echocardiography
    Yang, Haoyi
    Deng, Youbin
    Li, Chunlei
    Bi, Xiaojun
    Pan, Min
    Chang, Qing
    Journal of Huazhong University of Science and Technology - Medical Science, 2002, 22 (02): : 164 - 167
  • [10] Clinical pharmacology of multiple-dose losartan, an angiotensin II receptor antagonist, in patients with essential hypertension
    Sasaki, M
    Fujimura, A
    Harada, K
    Sunaga, K
    Ebihara, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (05): : 403 - 408